Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
US Department of Justice
US Army
Queensland Health
Boehringer Ingelheim
Julphar
Deloitte
Cipla
QuintilesIMS

Generated: April 21, 2018

DrugPatentWatch Database Preview

DILACOR XR Drug Profile

« Back to Dashboard

Which patents cover Dilacor Xr, and when can generic versions of Dilacor Xr launch?

Dilacor Xr is a drug marketed by Allergan Sales Llc and is included in one NDA.

The generic ingredient in DILACOR XR is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.
Drug patent expirations by year for DILACOR XR
Synonyms for DILACOR XR
(+)-3-acetoxy-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-2,3-dihydro-1,5benzothiazepine-4(5h)-one
(+)-5-[2-(Dimethylamino)ethyl]-cis-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate (ester)
[3H]-(+)-cis-diltiazem
[3H](+)-cis-diltiazem
[5-(2-dimethylaminoethyl)-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate
[5-(2-Dimethylaminoethyl)-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl]acetate
1,5-benzothiazepin-4(5h)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-
1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-, (2S-cis)-
1,5-Benzothiazepin-4(5H)-one,3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-,(2R,3R)-rel-
2-(4'-methoxyphenyl)-3-acetoxy-5-(N,N-dimethylaminoethyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one
3-Acetoxy-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one
3-acetoxy-5-[2- ethyl]-2,3-dihydro-2- -1,5-benzothiazepin-4 -one
3-acetoxy-5-[2- ethyl]-2,3-dihydro-2-1,5-benzothiazepin-4 -one
3-Acetyloxy-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one
34933-06-7
3B1-004607
5-(2-(Dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate
5-[2-(Dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate
5-[2-(Dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate #
5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2H,3H-benzo[b]1,4-thiazep in-3-yl acetate
56209-45-1
AB00053434_02
AC1L1F4B
AC1Q6LHZ
Acetic acid 5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester
ACM34933067
AK391573
AKOS000280681
AKOS024304397
BAS 00462422
BRD-A69636825-003-02-1
BSPBio_002398
CHEBI:82814
CHEMBL603584
cis-3-Acetoxy-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one
CTK5A4786
D04ALU
DivK1c_000004
EINECS 252-295-2
EINECS 260-060-0
GTPL2512
HE386152
HSUGRBWQSSZJOP-UHFFFAOYSA-N
I09-0442
IDI1_000004
KBio1_000004
KBio2_000724
KBio2_003292
KBio2_005860
KBioGR_001844
KBioSS_000724
l-Diltiazem
MCULE-6224711619
MLS006012029
NCGC00015332-03
NCGC00015332-04
NCGC00263934-01
NINDS_000004
Oprea1_266240
PL008374
PL054727
SBI-0051307.P002
SCHEMBL614334
SMR000768688
SPBio_001812
Spectrum_000244
Spectrum2_001736
Spectrum4_001262
Spectrum5_001750
ST50230615
STL483758

US Patents and Regulatory Information for DILACOR XR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan Sales Llc DILACOR XR diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020092-001 May 29, 1992 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Sales Llc DILACOR XR diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020092-002 May 29, 1992 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Sales Llc DILACOR XR diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020092-003 May 29, 1992 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for DILACOR XR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan Sales Llc DILACOR XR diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020092-002 May 29, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Sales Llc DILACOR XR diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020092-002 May 29, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Sales Llc DILACOR XR diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020092-003 May 29, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Sales Llc DILACOR XR diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020092-001 May 29, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Fuji
Boehringer Ingelheim
US Department of Justice
Mallinckrodt
Argus Health
Baxter
Cipla
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.